Active Pharmaceutical Ingredient Market to Witness Growth, Increasing Proliferation of Abbreviated New Drug Applications a Key Driver

ALBANY, New York, June 04, 2016 - Market Research Hub (MRH) has added the report ‘Active Pharmaceutical Ingredient Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023’ to its offering. This report provides a comprehensive evaluation of the market and incorporates an extensive quality analysis of the major dynamics impacting the development of the global pharmaceutical ingredient market. The market attractiveness evaluation on the basis of geography has also been encapsulated in the report. In addition, the report throws light on the event impact evaluation for the active pharmaceutical ingredient market.

The first section of the report presents an introduction to the global active pharmaceutical ingredients market. This section comprises the definition of active pharmaceutical ingredients. An active pharmaceutical ingredients (APIs) are a combination of substances or a single substance that is utilized in a finished pharmaceutical product (FPP) and is aimed to furnish any kind of pharmacological activity. They are also utilized to have a direct impact in the cure, mitigation, diagnosis, prevention or treatment of a disease. APIs are highly utilized for manufacturing safe and effective medicines and are bulk products employed as raw materials in formulations.

Browse Full Report with TOC @ http://www.marketresearchhub.com/report/active-pharmaceutical-ingredients-api-market-brandedgenericover-the-counter-chemicalbiological-captivecontract-manufactured-by-geography-and-by-therapeutic-area-global-industry-analysis-size-share-growth-trends-and-forecast-2014-2020-report.html

Moving next, the dynamics impacting the development of the market have been presented. The rising expenditures in healthcare and the swiftly growing geriatric population are the major factors stimulating the growth of the active pharmaceutical ingredient market. In addition, the increasing proliferation of Abbreviated New Drug Applications (ANDA) in the past few years will further augment the development of this market. Furthermore, the development of the Asia Pacific and the Rest of the World (RoW) healthcare markets and the patent expiry of the key biological drugs within the EU and the U.S. are the key opportunities in the market. On the other hand, the unfavorable regulatory policies imposed globally may inhibit the development of the market in the coming years.

The next section of the report throws light on the segmentation of the active pharmaceutical ingredient market. On the basis of manufacturing process, the market is segmented into contract manufacturing and captive manufacturing. In terms of API type, the report segments the market into biological API and synthetic chemical API. By drug type, the report segments the market into generic, branded, and OTC prescription drugs. By therapeutic area, the report segments the market into cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, and other therapeutics uses. Geographically, the report segments the market into North America, Asia Pacific, Rest of Asia Pacific, Europe, and Rest of the World (RoW).

The report suggest that the emerging players and the already established players in the global active pharmaceutical ingredient market can enhance their businesses in the market by the following two ways: Firstly, by expansion of their manufacturing capacities through acquisitions within promising geographies and secondly, by achieving cost leadership within particular API molecules. Hence, these have emerged as major opportunity areas in the global active pharmaceutical ingredient market.

Download Free Sample Report with TOC in a PDF Format: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=269804

At the end of the report, the company profiles of the prominent players operating in the market have been presented. Some of these players are BASF SE, Allergan plc., Boehringer Ingelheim GmbH, Dr. Reddy's Laboratories, Cambrex Corporation, Lonza Group, Pfizer, Inc., Sandoz (Novartis AG), and Mylan N.V., among others.

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

90 State Street,
Albany, NY 12207,
United States
Toll Free : 866-997-4948 (US-Canada)
Tel : +1-518-621-2074
Email : sales@marketresearchhub.com
Website : http://www.marketresearchhub.com/

This release was published on openPR.